Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Depression News

Severity, Duration Of Depression Associated With Risk Of Death Among Patients With Coronary Heart Disease

Main Category: Depression
Also Included In: Cardiovascular / Cardiology;  Heart Disease;  Psychology / Psychiatry
Article Date: 08 Sep 2009 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Among patients with both major depression and acute coronary syndrome, those with more severe depression within a few weeks of hospitalization for a cardiac event and those whose depression does not improve within six months appear to have more than double the risk of dying over a seven-year period, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

About one-fifth of individuals experience major depression in the first few weeks following a heart attack, according to background information in the article. Depression is associated with an increased risk of death after acute coronary syndrome, a term for cardiac events such as heart attack or unstable angina (chest pain).

Alexander H. Glassman, M.D., of Columbia University Medical Center and New York State Psychiatric Institute, New York, observed participants in a study assessing the safety and effectiveness of antidepressants following heart attack (the Sertraline Antidepressant Heart Attack Randomized Trial, or SADHART) to establish features of major depression associated with long-term risk of death. A total of 361 participants who were hospitalized for acute coronary syndromes between 1997 and 1999 and determined to have major depression were tracked through September 2007.

During a median (midpoint) of 6.7 years of follow-up, 75 participants (20.9 percent) died. Severity of depression during hospitalization for acute coronary syndromes was strongly associated with a significantly increased risk of death. Regardless of whether they took antidepressants, those whose depression had improved substantially at six months had significantly lower death rates-33 of 211 patients (15.6 percent) who were very much or much improved died, compared with 42 of 148 patients (28.4 percent) whose depression showed little or no improvement.

Risk of death during the study period did not appear to be associated with whether patients had previous episodes of depression, whether their depression developed before or after their cardiac event or whether they took antidepressants during the first six months following hospitalization.

"Depression is a syndrome with multiple pathways to a similar clinical picture. In patients with active coronary heart disease, it seems likely that the association with depression is a two-way street, and each can aggravate the other," they conclude. "Because persistent depression increases mortality and decreases medication adherence, physicians need to aggressively treat depression and be diligent in promoting adherence to guideline cardiovascular drug therapy."

Arch Gen Psychiatry. 2009;66[9]:1022-1029.

Source
Archives of General Psychiatry




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
Targacept Presents Data From Highly Successful Phase 2b Trial Of TC-5214 As Augmentation Treatment For Major Depressive Disorder
16 Oct 2009
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced the presentation of data from its recently completed Phase 2b...


Seasonal Depression image Seasonal Depression

Every winter, when the days get shorter, people with seasonal affective disorder, also known as SAD, experience depression. Learn how light can help chase away the winter blues...

Treating Major Depression image Treating Major Depression

Major depression is more than just suffering from a bad mood. It can affect just about everything you do, from how you sleep at night to how well you perform your job. Learn how you can feel better...

View more videos...